Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease
Open Access
- 18 February 2008
- journal article
- review article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 30 (2) , 91-94
- https://doi.org/10.1111/j.1751-553x.2007.00978.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Role Of von Willebrand Factor In Hemorrhagic And Thrombotic DisordersCritical Reviews in Clinical Laboratory Sciences, 2007
- 2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease.British Journal of Haematology, 2006
- Distinguishing between type 2B and pseudo‐von Willebrand disease and its clinical importanceBritish Journal of Haematology, 2006
- Qualitative disorders of platelets and megakaryocytesJournal of Thrombosis and Haemostasis, 2005
- Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand diseaseBlood, 2005
- Inherited Thrombocytopenias: Molecular MechanismsSeminars in Thrombosis and Hemostasis, 2004
- Structural determinants within platelet glycoprotein Ibα involved in its binding to von Willebrand factorPlatelets, 2000
- Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.Proceedings of the National Academy of Sciences, 1991
- von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.Journal of Clinical Investigation, 1983
- Pseudo-von Willebrand's DiseaseNew England Journal of Medicine, 1982